Application
GLB1L2 Antibody (C-term) western blot analysis in CEM cell line lysates (35ug/lane).This demonstrates the GLB1L2 antibody detected the GLB1L2 protein (arrow).Application
GLB1L2 antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human prostate carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the GLB1L2 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | GLB1L2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | GLB1L2 Beta-galactosidase-1-like protein 2 |
|---|---|
| Molecular Weight(MW) | 72079 Da |
| Tissue Specificity | This GLB1L2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 482-511 amino acids from the C-terminal region of human GLB1L2. |
| Cellular Localization | Secreted (Potential). |
| Entrez Gene | 89944 |
|---|---|
| Nucleotide Accession | NP_612351.2 |
Application
GLB1L2 Antibody (C-term) western blot analysis in CEM cell line lysates (35ug/lane).This demonstrates the GLB1L2 antibody detected the GLB1L2 protein (arrow).
Application
GLB1L2 antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human prostate carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the GLB1L2 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
